BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14749627)

  • 1. Cannabinoids and the human uterus during pregnancy.
    Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
    Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cannabinoids upon the uptake of folic acid by BeWo cells.
    Araújo JR; Gonçalves P; Martel F
    Pharmacology; 2009; 83(3):170-6. PubMed ID: 19145103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
    Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW
    J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide effects on 5-HT(3) receptors in vivo.
    Rácz I; Bilkei-Gorzo A; Markert A; Stamer F; Göthert M; Zimmer A
    Eur J Pharmacol; 2008 Oct; 596(1-3):98-101. PubMed ID: 18775693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
    Klegeris A; Bissonnette CJ; McGeer PL
    Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
    Baldassano S; Serio R; Mule' F
    Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
    Farquhar-Smith WP; Jaggar SI; Rice AS
    Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of endocannabinoid receptors in the human adrenal cortex.
    Ziegler CG; Mohn C; Lamounier-Zepter V; Rettori V; Bornstein SR; Krug AW; Ehrhart-Bornstein M
    Horm Metab Res; 2010 Feb; 42(2):88-92. PubMed ID: 19862666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
    Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells.
    Gonçalves P; Araújo JR; Azevedo I; Martel F
    Pharmacology; 2008; 82(1):30-7. PubMed ID: 18431074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid ligand-receptor signaling in the mouse uterus.
    Das SK; Paria BC; Chakraborty I; Dey SK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.